Independent Director · Tarsus Pharmaceuticals, Inc. (TARS)

Andrew Goldberg director compensation at Tarsus Pharmaceuticals: $310K

Fiscal year 2025 director compensation for Andrew Goldberg at Tarsus Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Andrew Goldberg’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Andrew Goldberg and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Tarsus Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as Tarsus Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$68,556$120,732$120,996$0$310,284
FY2024$51,500$109,679$110,675—$271,854
FY2023$50,625$61,506$59,574—$171,705

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tarsus Pharmaceuticals, Inc. DEF 14A filed April 28, 2026, accession 0001819790-26-000028, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tarsus Pharmaceuticals, Inc. filed document, accession 0001819790-26-000028. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Tarsus Pharmaceuticals Board Governance Report

$310,284 Andrew Goldberg, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Tarsus Pharmaceuticals pays directors a $50,000 cash retainer and $270,000 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance

The rest of the Tarsus Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bhaskar ChaudhuriIndependent Director$315,728
Bobak AzamianChair of the Board—
David E.I. PyottIndependent Director—
Katherine GoodrichIndependent Director$306,728
Scott MorrisonIndependent Director$316,728
Wendy YarnoLead Independent Director$394,339
William J. LinkIndependent Director$313,228

The full Tarsus Pharmaceuticals compensation record

free company brief

This page is one director within Tarsus Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Order TARS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report